Supemtek TIVr solution for injection in pre-filled syringe

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, nurse or pharmacist.
• This vaccine has been prescribed for you only. Do not pass it on to others.
• If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1. What Supemtek TIVr is and what it is used for
2. What you need to know before you receive Supemtek TIVr
3. How Supemtek TIVr is given
4. Possible side effects
5. How to store Supemtek TIVr
6. Contents of the pack and other information

When a person is given Supemtek TIVr, the body’s natural defence (the immune system) produces protection against the influenza virus. None of the ingredients in the vaccine can cause flu.

As with all vaccines, Supemtek TIVr may not fully protect all persons who are vaccinated.

Flu can spread very fast.

• It is caused by different types of flu virus that can change every year. This is why you might need to be vaccinated every year.
• The greatest risk of catching flu is during the cold months between October and March.
• If you were not vaccinated in the autumn, it is still sensible to be vaccinated up until the spring since you run the risk of catching flu until then.

Your doctor will be able to recommend the best time to be vaccinated.

Talk to your doctor, pharmacist or nurse before receiving Supemtek TIVr.

As with all vaccines, Supemtek TIVr may not fully protect all persons who are vaccinated.

Before receiving the vaccine, tell your doctor, nurse or pharmacist if:

• you have a short-term illness with fever. Vaccination may need to be delayed until your fever has gone.
• you have a weakened immune system (immunodeficiency or you are taking medicines that affect the immune system such as cancer medicine (chemotherapy) or corticosteroid medicines).
• you have a bleeding problem or bruise easily.
• you have fainted with an injection before. Fainting can happen after, or even before an injection.

If any of the above apply to you (or you are not sure) talk to your doctor, pharmacist or nurse before receiving Supemtek TIVr.

Tell your doctor or nurse if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription or if you have recently received any other vaccine.

Supemtek TIVr may be given at the same time as other vaccines by using separate limbs.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this vaccine. Your doctor or pharmacist will help you to decide if you should receive Supemtek TIVr.

Supemtek TIVr has no or negligible effect on your ability to drive and use machines.

This vaccine contains less than 1 mmol sodium (23 mg) per dose, this means that it’s essentially ‘sodium free’.

One dose of 0.5 mL.

Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency room right away if you have an allergic reaction. It can be life-threatening.

Symptoms include:

• difficulty breathing, shortness of breath
• swelling of the face, lips, throat or tongue
• cold, clammy skin
• palpitations
• feeling dizzy, feeling weak, fainting
• rash or itching

The following side effects have been reported with recombinant influenza vaccines (Supemtek and Supemtek TIVr):

Very common (may affect more than 1 in 10 people):

• pain at the injection site
• feeling tired (fatigue)
• headache
• muscle pain and joint pain

Muscle pain and joint pain are common in adults aged 50 years and older.

Common (may affect up to 1 in 10 people):

• feeling sick (nausea)
• redness, swelling, hardening around the area where the vaccine is injected
• fever, shivering

Fever is rare in adults aged 50 years and older.

Uncommon (may affect up to 1 in 100 people):

• diarrhoea
• itching, skin irritation, rash
• flu-like symptoms
• cough, mouth and throat pain
• itching where the vaccine is injected

Itching is rare in adults aged 50 years and older.

Skin irritation and rash have not been reported in adults aged 50 years and older.

Flu-like symptoms have not been reported in adults aged 18-49 years.

Rare (may affect up to 1 in 1000 people):

• feeling dizzy
• hives

Feeling dizzy and hives have not been reported in adults aged 18-49 years.

Not known (cannot be estimated from the available data):

• neurological disorders that may result in stiff neck, confusion, numbness, pain and weakness of the limbs, loss of balance, loss of reflexes, paralysis of part or all the body (Guillain-Barré syndrome).

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.. By reporting side effects, you can help provide more information on the safety of this medicine.

One dose (0.5 mL) contains:

The active substances are influenza virus haemagglutinin (HA) proteins, of the following strains*:

A/Wisconsin/67/2022 (H1N1)pdm09-like strain

(A/West Virginia/30/2022) ............................................ 45 micrograms HA

A/Darwin/6/2021 (H3N2)-like strain

(A/Darwin/6/2021) ......................................................... 45 micrograms HA

B/Austria/1359417/2021-like strain

(B/Austria/1359417/2021) ............................................. 45 micrograms HA

* produced by recombinant DNA technology using a baculovirus expression system in a continuous insect cell line that is derived from Sf9 cells of the fall armyworm, Spodoptera frugiperda.

This vaccine complies with the World Health Organisation (WHO) recommendation (northern hemisphere) and EU recommendation for the 2023/2024 season.

The other ingredients are: polysorbate 20 (E432), sodium chloride, sodium phosphate monobasic, sodium phosphate dibasic, water for injections.

Supemtek TIVr is a solution for injection in a pre-filled syringe (ready to use syringe).

Supemtek TIVr is a clear and colourless solution.

A single syringe contains 0.5 mL of solution for injection.

Supemtek TIVr is available in packs containing 1, 5 or 10 pre-filled syringes without needle or with separate needle.

Not all pack sizes may be marketed.